CD4 and cancer: The clinical significance of our results was exploited via alignment with the cancer genome atlas (TCGA) for colon and rectal cancer (COADREAD) RNA-Seq dataset, which enabled us to identify a unique gene signature of CD4+ TILs associated with decreased disease-specific survival (DSS) in data from 512 CRC patients.